3.4. Combination Compounds Reduce Activated AKT and mTORC1 Levels, along with the Protein Levels of Glycolysis Rate-Limiting Enzymes, HK2 and GPI, in Treated MM Cells. This evidence concerns the gene AKT1 and Miyoshi myopathy.